Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of HU007 in Dry Eye Syndrome
NCT05743764Phase 3Completed
- Sponsor
- Huons
- Start
- Mar 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclosporine + trehalose in dry eye disease (DED), sponsored by Huons. Started Mar 2023; status: completed.
02
Drugs
cyclosporine + trehalose
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05743764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05743764.